Literature DB >> 25894436

Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome.

Andrés González García1, José Luis Callejas Rubio2, Raquel Ríos Fernández2, Norberto Ortego Centeno2.   

Abstract

Sjögren syndrome is a chronic, systemic, and autoimmune disorder that targets exocrine glands by remarkable B cell hyperactivity. Eventually, it is associated with extra-glandular clinical manifestations that affect essentially any organ system, including pulmonary involvement. Interstitial lung disease is one of the most serious pulmonary complications, and the early diagnosis is essential to initiate a prompt therapy. On the other hand, Sjögren syndrome could present concomitantly with several rheumatologic diseases such as systemic lupus erythematosus or rheumatoid arthritis. Pulmonary Langerhans Histiocytosis is a rare clonal proliferative disease characterized by pulmonary involvement by cells phenotypically similar to Langerhans cells. We describe the case of a nonsmoker 62-year-old woman with Sjögren syndrome who presented concomitantly a Pulmonary Langerhans Histiocytosis mimicking a pulmonary complication of its Sjögren. Fortunately, she had a well response to corticosteroids and azathioprine regimen. The aim of the paper is to emphasize the importance of the good differential diagnosis related to the pulmonary involvement. To the best of our knowledge, this is the first description of these two entities in the literature.

Entities:  

Keywords:  Azathioprine; CD1a-stained cells; Interstitial lung diseases; Pulmonary Langerhans Histiocytosis; Sarcoidosis; Sjögren syndrome

Mesh:

Substances:

Year:  2015        PMID: 25894436     DOI: 10.1007/s10067-015-2924-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

Review 1.  Pulmonary Langerhans'-cell histiocytosis.

Authors:  R Vassallo; J H Ryu; T V Colby; T Hartman; A H Limper
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

2.  Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients.

Authors:  M Koyama; T Johkoh; O Honda; N Mihara; T Kozuka; N Tomiyama; S Hamada; H Nakamura
Journal:  J Thorac Imaging       Date:  2001-10       Impact factor: 3.000

Review 3.  Primary Sjogren syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó-Almirall; Xavier Bosch
Journal:  BMJ       Date:  2012-06-14

4.  [Adult pulmonary Langerhans' cell histiocytosis: approach to the reality of the Spanish population].

Authors:  Diego Castillo; Iñigo Martin-Arroyo; Amalia Moreno; Eva Balcells; Ana Villar; Vanesa Vicens-Zygmunt; Montserrat Vendrell; Sonia Belda; Karina Portillo; Dalila Kettou; Francisco Aparicio; Maria Molina-Molina
Journal:  Med Clin (Barc)       Date:  2014-04-13       Impact factor: 1.725

5.  Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X.

Authors:  N Schönfeld; W Frank; S Wenig; P Uhrmeister; E Allica; H Preussler; A Grassot; R Loddenkemper
Journal:  Respiration       Date:  1993       Impact factor: 3.580

6.  A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Authors:  Rachel K Hoyles; Ross W Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlands; Nicole S L Goh; Christopher Roberts; Sujal Desai; Ariane L Herrick; Neil J McHugh; Noeleen M Foley; Stanley B Pearson; Paul Emery; Douglas J Veale; Christopher P Denton; Athol U Wells; Carol M Black; Roland M du Bois
Journal:  Arthritis Rheum       Date:  2006-12

7.  Interstitial lung disease in primary Sjögren syndrome.

Authors:  Joseph G Parambil; Jeffrey L Myers; Rebecca M Lindell; Eric L Matteson; Jay H Ryu
Journal:  Chest       Date:  2006-11       Impact factor: 9.410

8.  Pulmonary manifestations in Sjogren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients.

Authors:  Maiko Watanabe; Taio Naniwa; Masaki Hara; Toshinao Arakawa; Tomoyo Maeda
Journal:  J Rheumatol       Date:  2009-12-15       Impact factor: 4.666

9.  Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X.

Authors:  U Auerswald; J Barth; H Magnussen
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 10.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

View more
  1 in total

1.  Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.

Authors:  Anaïs Roeser; Fleur Cohen-Aubart; Paul Breillat; Makoto Miyara; Jean-François Emile; Frédéric Charlotte; Jean Donadieu; Zahir Amoura; Julien Haroche
Journal:  Haematologica       Date:  2019-03-28       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.